Financial Comparison: Establishment Labs (NASDAQ:ESTA) & NeuroOne Medical Technologies (NASDAQ:NMTC)

NeuroOne Medical Technologies (NASDAQ:NMTC) and Establishment Labs (NASDAQ:ESTA) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability.

Profitability

This table compares NeuroOne Medical Technologies and Establishment Labs’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NeuroOne Medical Technologies	N/A	N/A	N/A
Establishment Labs	N/A	N/A	N/A

Analyst Ratings

This is a summary of recent ratings and target prices for NeuroOne Medical Technologies and Establishment Labs, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeuroOne Medical Technologies	1	1	3	0	2.40
Establishment Labs	1	0	9	0	2.80

NeuroOne Medical Technologies presently has a consensus price target of $7.33, indicating a potential upside of 704.98%. Establishment Labs has a consensus price target of $96.11, indicating a potential upside of 45.28%. Given NeuroOne Medical Technologies’ higher probable upside, analysts clearly believe NeuroOne Medical Technologies is more favorable than Establishment Labs.

Institutional & Insider Ownership

16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. Comparatively, 72.9% of Establishment Labs shares are owned by institutional investors. 11.8% of NeuroOne Medical Technologies shares are owned by company insiders. Comparatively, 10.0% of Establishment Labs shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Valuation and Earnings

This table compares NeuroOne Medical Technologies and Establishment Labs”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeuroOne Medical Technologies	N/A	N/A	N/A	($0.95)	-0.96
Establishment Labs	N/A	N/A	N/A	($1.31)	-50.50

Establishment Labs is trading at a lower price-to-earnings ratio than NeuroOne Medical Technologies, indicating that it is currently the more affordable of the two stocks.

Summary

NeuroOne Medical Technologies beats Establishment Labs on 4 of the 7 factors compared between the two stocks.

About NeuroOne Medical Technologies

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.

About Establishment Labs

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.